Health
Novel T-cell therapy shows promise to treat COVID-19 in high-risk patients – Healio
An off-the-shelf, virus-specific T-cell therapy demonstrated proof of concept to enter a clinical trial for the treatment of severe COVID-19 infection, according…
Source/Disclosures
Source: Vasileiou S, et al. Abstract 612. Presented at: ASH Annual Meeting and Exposition (virtual meeting); Dec. 5-8, 2020.
Disclosures:
Vasileiou reports a consultant role with and research funding from AlloVir. Please see the abstract for all other researchers’ relevant financial disclosures.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
An off-the-shelf, virus-specific…
-
General21 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
General6 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News22 hours agoWorker rushed to hospital after becoming trapped in machinery during horror workplace accident in Salisbury
-
General19 hours agoRobin Williams’s daughter begs fans to stop making AI content of her father